Speaking at a recent Technology Networks’ symposium, Dr. Jason Reeves explained how AI is changing the development of ...

A study by the Neuropsychopharmacology and IBeA groups of the University of the Basque Country (UPV/EHU) paves the way to ...

The ALS research landscape is evolving rapidly, with groundbreaking advancements shaping the future of therapeutic ...

Artificial intelligence can help. The stories below highlight startup companies that use AI to spot patterns that humans ...

The Organ-on-a-Chip (OOAC) technology simulates various organ systems depending on the specific cell types seeded onto the ...

Angle announced on Friday the successful completion of assay development projects for AstraZeneca and Eisai, further ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

Shares of Elevation Oncology , Inc. (NASDAQ: ELEV) fell by 20% following the announcement that the company will discontinue the development of its drug candidate EO-3021. The decision came after ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...